Lista de obras - Laurence Chaperot - Dominio Público Uruguay

A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm

artículo científico publicado en 2016

A novel cancer vaccine strategy based on HLA-A*0201 matched allogeneic plasmacytoid dendritic cells

artículo científico publicado en 2010

Activation of the noncanonical NF-κB pathway by HIV controls a dendritic cell immunoregulatory phenotype.

artículo científico publicado en 2012

Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells.

artículo científico publicado en 2005

BDCA1+ cDC2s, BDCA2+ pDCs and BDCA3+ cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients

artículo científico publicado en 2020

CD2AP/SHIP1 complex positively regulates plasmacytoid dendritic cell receptor signaling by inhibiting the E3 ubiquitin ligase Cbl

artículo científico publicado en 2012

CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells.

artículo científico publicado en 2003

Characterization of circulating dendritic cells in melanoma: role of CCR6 in plasmacytoid dendritic cell recruitment to the tumor

artículo científico publicado en 2010

Characterization of species-specific genes regulated by E2-2 in human plasmacytoid dendritic cells

artículo científico publicado en 2015

Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection

scientific article published on 04 February 2019

Clinical and biologic features of CD4+CD56+ malignancies

scientific article published on 01 March 2002

Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses

artículo científico publicado en 2017

Death receptor 6 is a novel plasmacytoid dendritic cell-specific receptor and modulates type I interferon production.

artículo científico publicado en 2016

Deciphering the Impact of Early-Life Exposures to Highly Variable Environmental Factors on Foetal and Child Health: Design of SEPAGES Couple-Child Cohort

artículo científico publicado en 2019

Differentiation of anti-tumour cytotoxic T lymphocytes from autologous peripheral blood lymphocytes in non-Hodgkin's lymphomas

artículo científico publicado en 2002

Differentiation of antigen-presenting cells (dendritic cells and macrophages) for therapeutic application in patients with lymphoma

scientific article published on 01 September 2000

Diversification of circulating and tumor-infiltrating plasmacytoid DCs towards the P3 (CD80+ PDL1-)-pDC subset negatively correlated with clinical outcomes in melanoma patients

artículo científico publicado en 2022

Dual Role of the Tyrosine Kinase Syk in Regulation of Toll-Like Receptor Signaling in Plasmacytoid Dendritic Cells

artículo científico publicado en 2016

Dysfunctional BTN3A together with deregulated immune checkpoints and type I/II IFN dictate defective interplay between pDCs and γδ T cells in melanoma patients, which impacts clinical outcomes

artículo científico publicado en 2021

E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c-FLIP(short).

artículo científico publicado en 2006

Epigenetic regulator CXXC5 recruits DNA demethylase Tet2 to regulate TLR7/9-elicited IFN response in pDCs

artículo científico publicado en 2017

Exploration of the lysis mechanisms of leukaemic blasts by chimaeric T-cells.

artículo científico publicado en 2010

Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells

artículo científico publicado en 2005

Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia.

artículo científico publicado en 2009

From the study of tumor cell immunogenicity to the generation of antitumor cytotoxic cells in non-Hodgkin's lymphomas.

artículo científico publicado en 2000

HIV triggers immunoregulatory dendritic cells and regulatory T cells through the non-canonical NF-kB pathway.

artículo científico publicado en 2012

HLA-A(*)0201(+) plasmacytoid dendritic cells provide a cell-based immunotherapy for melanoma patients.

artículo científico publicado en 2012

Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasms

artículo científico publicado en 2016

Highly efficient transduction of human plasmacytoid dendritic cells without phenotypic and functional maturation.

artículo científico publicado en 2009

Identification of a leukemic counterpart of the plasmacytoid dendritic cells.

artículo científico publicado en 2001

In situ leukemic plasmacytoid dendritic cells pattern of chemokine receptors expression and in vitro migratory response

artículo científico publicado en 2004

In vitro PUVA treatment triggers calreticulin exposition and HMGB1 release by dying T lymphocytes in GVHD: New insights in extracorporeal photopheresis

artículo científico publicado en 2019

In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas.

artículo científico publicado en 2002

Induction of antiviral cytotoxic T cells by plasmacytoid dendritic cells for adoptive immunotherapy of posttransplant diseases.

artículo científico publicado en 2011

Innate sensing of HIV-infected cells

artículo científico publicado en 2011

La photochimiothérapie extracorporelle ou l’immunothérapie par cellules modifiées par photochimie

scientific article published on 11 February 2010

Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts

scientific article published on 01 February 2004

Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: an important role of co-stimulatory molecules CD80 (B7-1) and CD86 (B7-2) in stimulation by tumo

artículo científico publicado en 1995

Mechanisms of TRAIL-induced apoptosis in leukemic plasmacytoid dendritic cells.

artículo científico publicado en 2006

Multi-organ failure induced by Nivolumab in the context of allo-stem cell transplantation

artículo científico publicado en 2019

NFATC3 promotes IRF7 transcriptional activity in plasmacy--toid dendritic cells.

artículo científico publicado en 2016

Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus.

artículo científico publicado en 2011

P16-52. HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism.

artículo científico publicado en 2009

Photochemotherapy Induces a Faster Apoptosis of Alloreactive Activated T Cells Than of Nonalloreactive Resting T Cells in Graft Versus Host Disease

artículo científico publicado en 2010

Photochemotherapy induces the apoptosis of monocytes without impairing their function.

artículo científico publicado en 2010

Photopheresis efficacy in the treatment of rheumatoid arthritis: a pre-clinical proof of concept

artículo científico publicado en 2019

Plasma Circulating Tumor DNA Levels for the Monitoring of Melanoma Patients: Landscape of Available Technologies and Clinical Applications.

artículo científico publicado en 2017

Plasmacytoid dendritic cells and dermatological disorders: focus on their role in autoimmunity and cancer.

scientific article published on 22 October 2009

Protein Tyrosine Phosphatase PTPRS Is an Inhibitory Receptor on Human and Murine Plasmacytoid Dendritic Cells

scientific journal article

Quantification of cellular adhesion molecules on malignant B cells from non-Hodgkin's lymphoma

scientific article published on 01 September 1999

Quantitative analysis detects ubiquitous expression of apoptotic regulators in B cell non-Hodgkin's lymphomas

scientific article published on 01 October 1999

Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease

article

Relationships between susceptibility to LAK cell-mediated lysis, conjugate formation and expression of adhesion molecules in B-cell derived non-Hodgkin's lymphomas

artículo científico publicado en 1997

SCARB2/LIMP-2 Regulates IFN Production of Plasmacytoid Dendritic Cells by Mediating Endosomal Translocation of TLR9 and Nuclear Translocation of IRF7.

artículo científico publicado en 2015

Self-adjuvanting influenza candidate vaccine presenting epitopes for cell-mediated immunity on a proteinaceous multivalent nanoplatform.

artículo científico publicado en 2013

Synthetic self-assembling ADDomer platform for highly efficient vaccination by genetically encoded multiepitope display

scientific article published on 25 September 2019

T-cell receptor diversity as a prognostic biomarker in melanoma patients

scientific article published on 23 January 2020

TLR7 stimulation in human plasmacytoid dendritic cells leads to the induction of early IFN-inducible genes in the absence of type I IFN

artículo científico publicado en 2009

Tartrate-Resistant Acid Phosphatase Deficiency in the Predisposition to Systemic Lupus Erythematosus

artículo científico publicado en 2016

The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic Cells.

artículo científico publicado en 2018

The avidity of tumor-specific T cells amplified by a plasmacytoid dendritic cell-based assay can predict the clinical evolution of melanoma patients

artículo científico publicado en 2017

The features of circulating and tumor-infiltrating γδ T cells in melanoma patients display critical perturbations with prognostic impact on clinical outcome

artículo científico publicado en 2019

Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis.

artículo científico publicado en 1998

Virosome-mediated delivery of tumor antigen to plasmacytoid dendritic cells

artículo científico publicado en 2007

Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells.

artículo científico publicado en 2006

Whole lymphoma B cells allow efficient cross-presentation of antigens by dendritic cells.

scientific article published on January 2008

[GENiusVac, a novel antitumor vaccine strategy based on allogeneic plasmacytoid dendritic cells]

artículo científico publicado en 2011

Lista de obras de Laurence Chaperot

A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm

A novel cancer vaccine strategy based on HLA-A*0201 matched allogeneic plasmacytoid dendritic cells

Activation of the noncanonical NF-κB pathway by HIV controls a dendritic cell immunoregulatory phenotype.

Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells.

BDCA1<sup>+</sup> cDC2s, BDCA2<sup>+</sup> pDCs and BDCA3<sup>+</sup> cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients

CD2AP/SHIP1 complex positively regulates plasmacytoid dendritic cell receptor signaling by inhibiting the E3 ubiquitin ligase Cbl

CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells.

Characterization of circulating dendritic cells in melanoma: role of CCR6 in plasmacytoid dendritic cell recruitment to the tumor

Characterization of species-specific genes regulated by E2-2 in human plasmacytoid dendritic cells

Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection

Clinical and biologic features of CD4+CD56+ malignancies

Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses

Death receptor 6 is a novel plasmacytoid dendritic cell-specific receptor and modulates type I interferon production.

Deciphering the Impact of Early-Life Exposures to Highly Variable Environmental Factors on Foetal and Child Health: Design of SEPAGES Couple-Child Cohort

Differentiation of anti-tumour cytotoxic T lymphocytes from autologous peripheral blood lymphocytes in non-Hodgkin's lymphomas

Differentiation of antigen-presenting cells (dendritic cells and macrophages) for therapeutic application in patients with lymphoma

Diversification of circulating and tumor-infiltrating plasmacytoid DCs towards the P3 (CD80<sup>+</sup> PDL1<sup>-</sup>)-pDC subset negatively correlated with clinical outcomes in melanoma patients

Dual Role of the Tyrosine Kinase Syk in Regulation of Toll-Like Receptor Signaling in Plasmacytoid Dendritic Cells

Dysfunctional BTN3A together with deregulated immune checkpoints and type I/II IFN dictate defective interplay between pDCs and γδ T cells in melanoma patients, which impacts clinical outcomes

E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c-FLIP(short).

Epigenetic regulator CXXC5 recruits DNA demethylase Tet2 to regulate TLR7/9-elicited IFN response in pDCs

Exploration of the lysis mechanisms of leukaemic blasts by chimaeric T-cells.

Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells

Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia.

From the study of tumor cell immunogenicity to the generation of antitumor cytotoxic cells in non-Hodgkin's lymphomas.

HIV triggers immunoregulatory dendritic cells and regulatory T cells through the non-canonical NF-kB pathway.

HLA-A(*)0201(+) plasmacytoid dendritic cells provide a cell-based immunotherapy for melanoma patients.

Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasms

Highly efficient transduction of human plasmacytoid dendritic cells without phenotypic and functional maturation.

Identification of a leukemic counterpart of the plasmacytoid dendritic cells.

In situ leukemic plasmacytoid dendritic cells pattern of chemokine receptors expression and in vitro migratory response

In vitro PUVA treatment triggers calreticulin exposition and HMGB1 release by dying T lymphocytes in GVHD: New insights in extracorporeal photopheresis

In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas.

Induction of antiviral cytotoxic T cells by plasmacytoid dendritic cells for adoptive immunotherapy of posttransplant diseases.

Innate sensing of HIV-infected cells

La photochimiothérapie extracorporelle ou l’immunothérapie par cellules modifiées par photochimie

Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts

Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: an important role of co-stimulatory molecules CD80 (B7-1) and CD86 (B7-2) in stimulation by tumo

Mechanisms of TRAIL-induced apoptosis in leukemic plasmacytoid dendritic cells.

Multi-organ failure induced by Nivolumab in the context of allo-stem cell transplantation

NFATC3 promotes IRF7 transcriptional activity in plasmacy--toid dendritic cells.

Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus.

P16-52. HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism.

Photochemotherapy Induces a Faster Apoptosis of Alloreactive Activated T Cells Than of Nonalloreactive Resting T Cells in Graft Versus Host Disease

Photochemotherapy induces the apoptosis of monocytes without impairing their function.

Photopheresis efficacy in the treatment of rheumatoid arthritis: a pre-clinical proof of concept

Plasma Circulating Tumor DNA Levels for the Monitoring of Melanoma Patients: Landscape of Available Technologies and Clinical Applications.

Plasmacytoid dendritic cells and dermatological disorders: focus on their role in autoimmunity and cancer.

Protein Tyrosine Phosphatase PTPRS Is an Inhibitory Receptor on Human and Murine Plasmacytoid Dendritic Cells

Quantification of cellular adhesion molecules on malignant B cells from non-Hodgkin's lymphoma

Quantitative analysis detects ubiquitous expression of apoptotic regulators in B cell non-Hodgkin's lymphomas

Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease

Relationships between susceptibility to LAK cell-mediated lysis, conjugate formation and expression of adhesion molecules in B-cell derived non-Hodgkin's lymphomas

SCARB2/LIMP-2 Regulates IFN Production of Plasmacytoid Dendritic Cells by Mediating Endosomal Translocation of TLR9 and Nuclear Translocation of IRF7.

Self-adjuvanting influenza candidate vaccine presenting epitopes for cell-mediated immunity on a proteinaceous multivalent nanoplatform.

Synthetic self-assembling ADDomer platform for highly efficient vaccination by genetically encoded multiepitope display

T-cell receptor diversity as a prognostic biomarker in melanoma patients

TLR7 stimulation in human plasmacytoid dendritic cells leads to the induction of early IFN-inducible genes in the absence of type I IFN

Tartrate-Resistant Acid Phosphatase Deficiency in the Predisposition to Systemic Lupus Erythematosus

The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic Cells.

The avidity of tumor-specific T cells amplified by a plasmacytoid dendritic cell-based assay can predict the clinical evolution of melanoma patients

The features of circulating and tumor-infiltrating γδ T cells in melanoma patients display critical perturbations with prognostic impact on clinical outcome

Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis.

Virosome-mediated delivery of tumor antigen to plasmacytoid dendritic cells

Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells.

Whole lymphoma B cells allow efficient cross-presentation of antigens by dendritic cells.

[GENiusVac, a novel antitumor vaccine strategy based on allogeneic plasmacytoid dendritic cells]